<DOC>
	<DOCNO>NCT00010114</DOCNO>
	<brief_summary>RATIONALE : Genetic study may help understand genetic process involve development type cancer . PURPOSE : Genetic study learn gene involve development central nervous system tumor young child .</brief_summary>
	<brief_title>Genetic Study Newly Diagnosed Central Nervous System Tumors Young Children</brief_title>
	<detailed_description>OBJECTIVES : - Identify know gene significantly different level expression , use microarray gene chip analysis , infant newly diagnose metastatic v non-metastatic embryonal central nervous system tumor . - Determine protein expression gene identify microarray analysis involve cellular function regulate angiogenesis , invasion , metastasis patient population . - Determine quantity gene expression confirm translationally express gene use semi-quantitative polymerase chain reaction . OUTLINE : This multicenter study . Tumor sample analyze use microarray gene chip analysis . Differentially express gene evaluate protein expression standard immunohistochemistry and/or Western blot analysis , gene expression quantify semi-quantitative polymerase chain reaction . PROJECTED ACCRUAL : Approximately 80-100 patient ( 20-25 metastatic disease 60-75 non-metastatic disease ) accrue study within 4-5 year .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , newly diagnose , primary intracranial embryonal central nervous system tumor Medulloblastoma Primitive neuroectodermal tumor Medulloepithelioma Ependymoblastoma Neuroblastoma Pineoblastoma Atypical teratoid/rhabdoid tumor Intracranial germ cell tumor Choroid plexus carcinoma M positive ependymoma Potential enrollment PBTC001 therapeutic protocol PATIENT CHARACTERISTICS : Age : Under 3 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Prior steroid allow Radiotherapy : No prior radiotherapy Surgery : Not specify Other : No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
</DOC>